DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Terfenadine

Terfenadine

  • Prescribing Information for High-Dose Fexofenadine in the Management of Urticaria in Adults

    Prescribing Information for High-Dose Fexofenadine in the Management of Urticaria in Adults

  • Profile Profile Profile Profile Uses and Administration Adverse Effects And

    Profile Profile Profile Profile Uses and Administration Adverse Effects And

  • Antihistamines in the Treatment of Chronic Urticaria I Jáuregui,1 M Ferrer,2 J Montoro,3 I Dávila,4 J Bartra,5 a Del Cuvillo,6 J Mullol,7 J Sastre,8 a Valero5

    Antihistamines in the Treatment of Chronic Urticaria I Jáuregui,1 M Ferrer,2 J Montoro,3 I Dávila,4 J Bartra,5 a Del Cuvillo,6 J Mullol,7 J Sastre,8 a Valero5

  • Antihistamine Therapy in Allergic Rhinitis

    Antihistamine Therapy in Allergic Rhinitis

  • Inhibitory Effect of Terfenadine, a Selective H1 Histamine Antagonist, on Alcoholic Beverage-Induced Bronchoconstriction in Asthmatic Patients

    Inhibitory Effect of Terfenadine, a Selective H1 Histamine Antagonist, on Alcoholic Beverage-Induced Bronchoconstriction in Asthmatic Patients

  • Histamine and Antihistamines Sites of Action Conditions Which Cause Release Aron H

    Histamine and Antihistamines Sites of Action Conditions Which Cause Release Aron H

  • Clomipramine 25 Mg Capsules, Hard

    Clomipramine 25 Mg Capsules, Hard

  • Scratching Behavior in Mice Associated with Ige-Mediated Allergic Cutaneous Reaction and Its Pharmacological Characterization

    Scratching Behavior in Mice Associated with Ige-Mediated Allergic Cutaneous Reaction and Its Pharmacological Characterization

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Medications to Avoid in Long QT Syndrome

    Medications to Avoid in Long QT Syndrome

  • Medicines That Adversely Affect Allergy Skin Testing

    Medicines That Adversely Affect Allergy Skin Testing

  • Cytochrome P450 Drug Interaction Table

    Cytochrome P450 Drug Interaction Table

  • Pediatric Pharmacotherapy

    Pediatric Pharmacotherapy

  • Reference ID: 4742965 FULL PRESCRIBING INFORMATION: CONTENTS*

    Reference ID: 4742965 FULL PRESCRIBING INFORMATION: CONTENTS*

  • Medications to Stop Taking Before Allergy Testing

    Medications to Stop Taking Before Allergy Testing

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • (12) United States Patent (Lo) Patent No.: �US 8,480,637 B2

    (12) United States Patent (Lo) Patent No.: US 8,480,637 B2

  • (Therapeutic Products) Regulations 2015

    (Therapeutic Products) Regulations 2015

Top View
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Antihistamines and Driving-Related Behavior: a Review of the Evidence for Impairment by First- Versus Second-Generation H1-Antagonists
  • Rupatadine 10 and 20 Mg Are Effective
  • Motherisk Update Safety of Antihistamines During Pregnancy and Lactation
  • Customs Tariff - Schedule Xxi - 1
  • FUTURA STUDY-Evaluation of Efficacy and Safety of Rupatadine Fumarate in the Treatment of Persistent Allergic Rhinitis
  • Toxicology Brief” Was Contributed by Lisa Murphy, VMD, ASPCA Animal Poison Control Center, 1717 S
  • Effect of H Antihistamines Upon the Cardiovascular System
  • Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?
  • The Comparative Effects of Four Antihistamines on Isolated Rat Atria
  • The Effects of Topical (Gel) Astemizole and Terfenadine on Wound Healing D
  • Allegra (Fexofendine)
  • Histamine H1-Receptor Antagonists: Antihistaminic Agents
  • Heart Rhythm Disturbances Associated with Rupatadine: a Case Series from the Spanish and Portuguese Pharmacovigilance Systems
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0094438 A1 Mitchell (43) Pub
  • (2) Patent Application Publication (10) Pub. No.: US 2017/0020873 A1 Mitchell (43) Pub
  • Reference ID: 4440871 FULL PRESCRIBING INFORMATION
  • Drugs Associated with Qt Interval Prolongation2–65


© 2024 Docslib.org    Feedback